人附睾蛋白4在子宫内膜癌诊断与治疗中的研究进展被引量：4

Research progress of HE4 in the diagnosis and treatment of endometrial carcinoma

下载PDF

导出

摘要子宫内膜癌患者缺乏敏感性及特异性均高的血清肿瘤标志物,人附睾蛋白4(human epididymis protein 4,HE4)是近年发现的新肿瘤标志物,HE4基因最早是在人附睾上皮细胞中被发现的。研究发现,在子宫内膜癌细胞中检测到高水平的血清HE4。但HE4受多方面因素影响,除疾病、地域等因素外,仍需根据年龄及种族,界定血清HE4的临床参考范围。相比CA125,HE4有高的敏感性,而对于早期子宫内膜癌,更具有诊断价值,同时在子宫内膜癌的预后判断、疗效检测以及决定手术范围等方面都具有一定的意义。现就HE4在子宫内膜癌诊断与治疗中的研究进展进行综述。 Endometrial carcinoma lack of sensitive and distinctive tumor marker, human epididymis protein 4 （HE4） is the new tumor marker found in recent year. The gene of HFA is first discovered in human epididymis epithelium cell. A study demonstrates that the high level of HFA was found in endometrial carcinoma cells from all kind of tumor tissues. HFA is affected by various factors, except for pathema and region, we also need define the clinical reference ranges according to the age group and race. Compared with CA125, for the diagnosis,the prognosis, the curative effect observation, and the surgical resection extent of endometrial carcinoma, HE4 has more important significance. In this review, we summarize the research progress of HFA in the diagnosis and treatment of endometrial carcinoma.

作者郝丽娅李佩玲

机构地区哈尔滨医科大学附属第二医院妇产科

出处《现代肿瘤医学》 CAS 2015年第11期1597-1600,共4页 Journal of Modern Oncology

关键词人附睾蛋白4 子宫内膜癌血清糖类抗原125 human epididymis protein 4 endometrial carcinoma cancer antigen 125

分类号 R737.33 [医药卫生—肿瘤]

引文网络
相关文献

参考文献17

1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. Cancer J,2005,55(2) :74 - 108.
2Chao A, Tang YH, Lai CH, et al. Potential of an age - stratified CA125 cut - off value to improve the prognostic classification of patients with endometrial cancer [ J ]. Gynecol Oncol, 2013,129 (3) :500 -504.
3杨岚,郭友逢,王丽峰,王娟,文清华.CA_(125),CA_(19-9)在子宫内膜癌组织学和血清学中表达水平的差异性及相关性研究[J].中华妇幼临床医学杂志（电子版）,2013,9(2):166-168. 被引量：10
4Hellstrfim I, Raycraft J, Hayden LM, et al. The HFA ( WFDC2 ) pro- tein is a biomarker for ovarian carcinoma[ J]. Cancer Res,2003,63 ( 13 ) :3695 - 3700.
5Galgano MT, Hampton GM, Frierson HF. Comprehensive analysis of HE4 expression in normal and malignant human tissues [ J ]. Mod Patho1,2006,19 (6) :847 - 853.
6Urban N, Thorpe J, Karlan BY, et al. Interpretation of single and se- rial measures of HFA and CA125 in asymptnmatic women at high risk for ovarian cancer[ J]. Cancer Epidemiol Biomark Prey,2012, 21 ( 11 ) :2087 -2094.
7Mokhtar N,Thevarajah M,Ma N. Human epididymis protein 4 ref- erence intervals in a multiethnic asian women population[ J]. Asian Pacific J Cancer Prev,2011,13 (12) :6391 - 6395.
8张爱敏,张鹏.血清人附睾分泌蛋白E4和CA125联合检测对子宫内膜癌诊断的临床价值[J].中华妇产科杂志,2012,47(2):125-128. 被引量：52
9Bigantti E, Ragnoli M, Zanotti L, et al. Diagnostic and prognostic impact of serum HE4 detection in endometfial carcinoma patients [J]. Bri J Cancer,2011,104(9) :1418 -1425.
10Moore RG, Miller CM, Brown AK, et al. Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid ade- of the uterus [ J ]. Int J Gynecol Cancer, 2011,21 (7) :1185 - 1190.

二级参考文献22

1Hellstr(o)m I,Raycraft J,Hayden-Ledbetter M,et al.The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J].Cancer Res,2003,63 (3):695-3700.
2Anderson GL,Mclntosh M,Wu L,et al.Assessing lead time of selected ovarian cancer biomarkers:a nested case-control study[J].J Natl Cancer Inst,2010,102(1):26-38.
3Li J,Dowdy S,Tipton T,el al.HE4 as a biomarker for ovarian and endometrial cancer management[J].Expert Rev Mol Diagn,2009,9(6):555-566.
4Huhtinen K,Suvitie P,Hiissa J,et al.Serum HE4 concentration differentiates malignant ovarian turnours from ovarian endometriotic cysts[J].BrJ Cancer,2009,100(8):1315-1319.
5Moore R,Brown A,Miller M,et al.Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus[J].Gynecol Oncol,2008,1 10(2):196-201.
6Rahanam J,Steiner N,Hayes MP,et al.Chemotherapy for gynecologic cancers[J].Mt Sinai J Med,2009,76 (6):577-588.
7Farias-Eisner G,Su F,Robbins T,et al.Validation of serum biomarkers for detection of early-and late-stage endometrial cancer[J].Am J Obstet Gynecol,2010,202(1):73-75.
8Drapkin R,von Horsten HH,Lin YF,et al.Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J].Cancer Res,2005,65(6):2162-2169.
9Ozols RF,Bookman MA,Connolly DC,et al.Focus on epithelial ovarian cancer[J].Cancer Cell,2004,5(1):19-24.
10Roland IH,Yang WL,Yang DH,et al.Loss of surface and cyst epithelial banement membranes and preneoplastic morphologir changes in prophylactic oophorectomies[J].Cancer,2003,98(12):2607-2623.